PLCG2 can exist in eccDNA and contribute to the metastasis of non-small cell lung cancer by regulating mitochondrial respiration

• Published in: Cell death & disease 2023-04, Vol.14 (4), p.257-257, Article 257
• Main Authors: Yang, Yongfeng, Yang, Ying, Huang, Hong, Song, Tingting, Mao, Shengqiang, Liu, Dan, Zhang, Li, Li, Weimin
• Format: Article
• Language: English
• Subjects: 38/1; 38/23; 38/47; 38/77; 692/699/67/1612/1350; 692/699/67/2327; Antibodies; Biochemistry; Bioinformatics; Biomedical and Life Sciences; Carcinoma, Non-Small-Cell Lung - pathology; Cell Biology; Cell Culture; Cell Line; Chromosomes; Humans; Immunohistochemistry; Immunology; Life Sciences; Lung cancer; Lung Neoplasms - pathology; Metastases; Metastasis; Mitochondria; Non-small cell lung carcinoma; Respiration; RNA Interference; RNA-mediated interference; Small cell lung carcinoma; Transfection; Tumorigenesis; Western blotting
• ISSN: 2041-4889; 2041-4889
• DOI: 10.1038/s41419-023-05755-7

Extrachromosomal circular DNAs (eccDNAs) participate in tumorigenesis and tumor progression. However, the role and mechanism of eccDNAs have yet to be elucidated in non-small cell lung cancer (NSCLC). In our research, three surgically matched NSCLC tissue samples, NSCLC cell lines (H1299, A549, and H460), and a normal lung cell line (MRC-5) were used as study objects. High-throughput eccDNA sequencing and bioinformatics analysis were performed to study the distribution pattern and level of eccDNA expression. The upregulated candidate eccDNA-encoding PLCG2 was validated by routine PCR. Plasmid transfection, RNA interference, qRT‒PCR and western blotting experiments were used to verify the expression level of PLCG2. Our results showed that the chromosome distribution, length distribution, and genomic annotation of the eccDNAs were comparable between the NSCLC and normal groups. Nevertheless, there were no significant differences in eccDNAs between NSCLC tissues and matched normal lung tissues. The eccDNA derived from PLCG2 was upregulated in NSCLC cells. TCGA analysis and immunohistochemistry showed that PLCG2 was highly expressed in lung cancer tissues and tended to be associated with poor outcome. We also demonstrated that PLCG2 can promote metastasis through the regulation of mitochondrial respiration. These results suggested that PLCG2 identified by eccDNA sequencing acts as an oncogene and might be a new biomarker for NSCLC diagnosis and prognosis evaluation.